Linking endotypes to omics profiles in difficult-to-control asthma using the diagnostic Chinese medicine syndrome differentiation algorithm. (3rd May 2020)

• Record Type: Journal Article
• Authors: Song, Wenping; Zheng, Si; Li, Meng; Zhang, Xia; Cao, Rui; Ye, Cheng; Shao, Rongguang; Li, Guangxi; Li, Jiao; Liu, Shigang; Li, Hui; Li, Liang
• Is Part Of: Journal of asthma. Volume 57:Number 5(2020)
• Page Start: 532
• Page End: 542
• Publication Date: 2020-05-03
• Subjects: Cold/Hot pattern classification -- aldehyde dehydrogenase 3 family member A1 (ALDH3A1) -- whole genome DNA methylation -- metabolomics -- diagnostic biomarker; Asthma -- Periodicals; 616.238005
• DOI: 10.1080/02770903.2019.1590589
• Languages: English
• ISSNs: 0277-0903

Abstract

Abstract: Objective: Patients with difficult-to-control asthma have difficulty breathing almost all of the time, even leading to life-threatening asthma attacks. However, only few diagnostic markers for this disease have been identified. We aimed to take advantage of unique Chinese medicine theories for phenotypic classification and to explore molecular signatures in difficult-to-control asthma. Methods: The Chinese medicine syndrome differentiation algorithm (CMSDA) is a syndrome-scoring classification method based on the Chinese medicine overall observation theory. Patients with difficult-to-control asthma were classified into Cold- and Hot-pattern groups according to the CMSDA. DNA methylation and metabolomic profiles were obtained using Infinium Human Methylation 450 BeadChip and gas chromatography-mass spectrometer. Subsequently, an integrated bioinformatics analysis was performed to compare those two patterns and identify Cold/Hot-associated candidates, followed by functional validation studies. Results: A total of 20 patients with difficult-to-control asthma were enrolled in the study. Ten were grouped as Cold and 10 as Hot according to the CMSDA. We identified distinct whole-genome DNA methylation and metabolomic profiles between Cold- and Hot-pattern groups. ALDH3A1 gene exhibited variations in the DNA methylation probe cg10791966, while two metabolic pathways were associated with those two patterns. Conclusions: Our study introduced a novel diagnostic classification approach, the CMSDA, for difficult-to-control asthma. This is an alternative way to categorize diverse syndromes and link endotypes with omics profiles of this disease. ALDH3A1 might be a potential biomarker for precision diagnosis of difficult-to-control asthma.